摘要
目的探讨在乳腺癌改良根治术围手术期实施以人为本的以病种诊断相关分类为基础（DRGs）的成本控制及临床路径管理的意义及重要性。方法选择2009年2—8月在我中心行乳腺癌改良根治术的62例患者（除化疗外）为对照组；2009年9月至2010年4月在我中心实施以人为本的DRGs成本控制和临床路径管理的乳腺癌改良根治术的62例（除化疗外）患者为实验组；以其平均住院天数、平均住院费用、患者满意度等作为评价指标对两组进行统计分析。结果两组患者之间平均住院天数、平均住院费用、患者满意度等方面差异有统计学意义（P〈0．05）。结论乳腺癌改良根治术患者围手术期实施以人为本的DRGs成本控制和临床路径管理可以明显促进持续质量改进（CQI），缩短平均住院时间，降低医疗成本，提高患者满意度，值得大力推广。
Objective To study the meaning and importance of the implementation of diagnosis related groups（DRGS） based costs control and clinical path management in breast cancer patients undertaking modified radical mastectomy. Methods 62 patients undertook modified radical mastectomy from February to August in 2009 were in control group; 62 patients undertook modified radical mastectomy with the implementation of diagnosis related groups based costs control and clinical path management were in experimental group; To compare the differences of the average hospitalization days,average hospitalization fees and patients satisfaction between the two groups. Results There were statistical significances in the average hospitalization days ,average hospitalization fees and patients satisfaction between the two groups （ P 〈 0. 05 ）. Conclusions The implementation of diagnosis related groups based costs control and clinical path management in breast cancer patients undertook modified radical mastectomy can make a obvious promotion in continuous quality improvement, shorten the average hospitalization days, reduce the medical costs, increase patients satisfaction, and it is worth popularizing.
出处
《中华现代护理杂志》
2011年第7期758-760,共3页
Chinese Journal of Modern Nursing
基金
广东省深圳市科技局科研立项资助课题（201002039）
关键词
乳腺肿瘤
围手术期
临床路径
成本控制
Breast cancer
Perioperative period
Clinical paths
Cost control
